Intradermal immunization in the ear with cholera toxin and its non-toxic β subunit promotes efficient Th1 and Th17

David Meza-Sánchez1, Gibrán Pérez-Montesinos, Javier Sánchez-García

  • 1Unidad de Investigación Médica en Enfermedades Autoinmunes, Instituto Mexicano del Seguro Social, México.

Insights

Cholera toxin (CT) and its subunit CTB effectively prime CD4(+) T-cells via skin immunization, inducing a delayed-type hypersensitivity response dependent on migrating dendritic cells (DCs).

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • Investigating CD4(+) T-cell responses post-skin immunization is crucial.
  • Understanding the role of migrating dendritic cells (DCs) with adjuvants is key.

Purpose of the Study:

  • To evaluate CD4(+) T-cell priming after ear immunization using model antigens with cholera toxin (CT) or CTB adjuvant.
  • To determine the role of migrating skin cells and DC activation in the immune response.

Main Methods:

  • Ear immunization of mice with model antigens combined with CT or CTB.
  • Analysis of CD4(+) T-cell cytokine production (IFN-γ, IL-17, IL-4, IL-5).
  • Assessment of delayed-type hypersensitivity (DTH) responses and dependence on migrating cells.

Main Results:

  • CT immunization induced efficient antigen presentation, with CD4(+) T-cells producing IFN-γ and IL-17.
  • CTB activated DCs in the ear without visible inflammation, similar to CT.
  • Both CT and CTB elicited a DTH response dependent on migrating skin cells.
  • CT-induced DTH was dependent on IL-17 and partially on IFN-γ.

Conclusions:

  • CT and CTB are effective adjuvants for ear immunization, inducing robust CD4(+) T-cell responses.
  • Migrating DCs are essential for the adjuvant-induced immune response and DTH.
  • The study highlights the potential of CT and CTB in modulating T-cell differentiation and DTH.